Skip navigation
Cancer Biology and Therapeutics at Middlesex University - UCAS

There are other course options available which may have a different vacancy status or entry requirements – view the full list of options

Course summary

Our MSc programme will develop your knowledge and understanding of cancer diagnosis and therapeutics. The course will focus on up-to-date diagnostic techniques and emerging tumour markers and their potential applications in specific diagnostics for various types of cancers. In addition, you will be exploring drug delivery systems and learning to make drug carriers for targeting cancers using nanotechnology. You will also be trained to perform a range of molecular, cellular and proteomics laboratory techniques used for detecting tumour markers and monitoring therapeutic effects. Why study MSc/PGDip/PGCert Cancer Biology and Therapeutics at Middlesex University? This programme will provide not only the necessary framework and general concepts in the cancer research field, but also an updated advanced knowledge of cancer diagnosis and treatment. In addition, you will be led by experts who are in the front line of drug development and drug delivery and acquire useful novel laboratory skills using nanotechnology and Multiplex Immunoassay-NALIA system, which will equip you with the necessary/essential skills for pursuing a range of career options. You could also proceed to further scientific training or you would be well-equipped to carry out research. A final dissertation project will be supervised by experts focusing on a variety of cancer research areas. You will be working in laboratories equipped with up-to-date instrumentation including matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI- Tof MS), liquid chromatography (LC)- MS, gas chromatography (GC)- MS, conventional and quantitative PCR, flow cytometry, Confocal microscopy, Licor Imaging system and fully equipped histopathology laboratory and tissue culture facilities. Course highlights Acquire laboratory research skills in drug delivery using nanotechnology and multiplex immunoassays which stand at the frontline of the cancer clinical research arena Be taught by experts in the field of cancer research including academics and those working in the clinical area Develop expertise in a variety of laboratory techniques in our modern and well equipped laboratories forming part of the Centre for Investigative & Diagnostic Oncology led by Prof Ivan Roitt and Prof Richard Bayford. Introducing our new Learning Framework After working with our students to gather feedback on what they love most about our courses, we’re making some changes to how we structure and teach our programmes for the start of the 2024/25 academic year. You can find more information about how this course is affected by viewing the relevant course information sheet on our Learning Framework page: https://www.mdx.ac.uk/study/learning-framework/


Entry requirements

A 2:2 honours degree in Biomedical Sciences UG degree or equivalent


Fees and funding

Tuition fees

Republic of Ireland £10500* Whole course
EU £16800* Whole course
England £10500* Whole course
Northern Ireland £10500* Whole course
Scotland £10500* Whole course
Wales £10500* Whole course
Channel Islands £10500* Whole course
International £16800* Whole course

*This is a provisional fee and subject to change.

Tuition fee status depends on a number of criteria and varies according to where in the UK you will study. For further guidance on the criteria for home or overseas tuition fees, please refer to the UKCISA website .

Additional fee information

No additional fees or cost information has been supplied for this course, please contact the provider directly.
Cancer Biology and Therapeutics at Middlesex University - UCAS